CICI, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 355
NA - Nord America 272
AS - Asia 42
SA - Sud America 8
AF - Africa 3
Totale 680
Nazione #
US - Stati Uniti d'America 271
IE - Irlanda 152
SE - Svezia 58
DE - Germania 42
IT - Italia 34
CZ - Repubblica Ceca 21
SG - Singapore 19
UA - Ucraina 14
CN - Cina 13
GB - Regno Unito 11
FI - Finlandia 9
HK - Hong Kong 6
NL - Olanda 4
PE - Perù 4
BE - Belgio 2
BR - Brasile 2
CI - Costa d'Avorio 2
FR - Francia 2
GR - Grecia 2
RO - Romania 2
AR - Argentina 1
CL - Cile 1
IN - India 1
JP - Giappone 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MX - Messico 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 680
Città #
Dublin 152
Chandler 58
Nyköping 54
Ashburn 19
Brno 18
Los Angeles 15
Munich 15
Boardman 13
Princeton 12
Singapore 12
Foggia 10
London 10
New York 10
Helsinki 9
Jacksonville 7
West Jordan 7
Wilmington 6
Chicago 5
San Severo 4
Santa Clara 4
Bologna 3
Des Moines 3
Olomouc 3
Potenza 3
Shanghai 3
Washington 3
Abidjan 2
Altamura 2
Amsterdam 2
Athens 2
Beijing 2
Brussels 2
Council Bluffs 2
Iasi 2
Jiaxing 2
Lima 2
Naples 2
Nuremberg 2
Roccastrada 2
Tappahannock 2
Bari 1
Buenos Aires 1
Frankfurt am Main 1
Geislingen an der Steige 1
Guangzhou 1
Gunzenhausen 1
Hanover 1
Hefei 1
Kyiv 1
Lucera 1
Mexico City 1
Mykolayiv 1
Naaldwijk 1
Norwalk 1
Novokuznetsk 1
Oujda 1
Paris 1
Pune 1
Redmond 1
Redwood City 1
Riga 1
Santa Venerina 1
Seattle 1
Shenzhen 1
São Paulo 1
Taranto 1
Ulaanbaatar 1
Totale 513
Nome #
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 78
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 74
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 53
Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study 52
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 49
Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study 46
Growth factors: Do they play a role in entheseal involvement in psoriatic arthritis and undifferentiated spondyloarthritis patients? 43
Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis 42
Molecular basis of bone aging 42
Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases 39
Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis 37
HCV and Autoimmunity in Rheumatic Diseases 35
The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease 34
Effects of different vitamin d supplementation schemes in post-menopausal women: A monocentric open-label randomized study 34
Osteoblast role in the pathogenesis of rheumatoid arthritis 31
Disease modification and symptom relief in osteoarthritis using a mutated GCP-2/CXCL6 chemokine 24
Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study 21
Totale 734
Categoria #
all - tutte 7.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 1 1 0 3 0 2 0
2020/202127 1 2 3 0 3 0 3 6 4 3 0 2
2021/202275 4 8 1 0 13 2 0 11 11 6 0 19
2022/2023384 30 27 17 12 11 27 2 36 173 7 14 28
2023/2024183 27 5 13 8 6 39 4 3 1 18 9 50
2024/202558 26 3 12 10 7 0 0 0 0 0 0 0
Totale 734